定坤丹在氯米芬促排周期中对薄型子宫内膜的疗效观察

doi:10.3969/j.issn.1006-7795.2023.04.008

首都医科大学学报 ›› 2023, Vol. 44 ›› Issue (4): 550-554.doi: 10.3969/j.issn.1006-7795.2023.04.008

• 妇科内分泌绝经与生育力保护 • 上一篇下一篇

定坤丹在氯米芬促排周期中对薄型子宫内膜的疗效观察

金凤羽¹, 阮祥燕^1*, 秦爽¹, 许新¹, 杨瑜¹, 谷牧青¹, 李妍秋¹, 杜娟¹, 程姣姣¹, 尹晓丹²

1.首都医科大学附属北京妇产医院/北京妇幼保健院内分泌科，北京 100026; 2.首都医科大学附属北京妇产医院/北京妇幼保健院中医科，北京 100026

收稿日期:2023-05-09 出版日期:2023-08-21 发布日期:2023-07-26
通讯作者: 阮祥燕 E-mail:ruanxiangyan@ccmu.edu.cn
基金资助:
北京市属医院科研培育计划项目（PZ2019031），北京市医院管理中心“登峰”人才培养计划项目（DFL20181401）

Effect of Dingkundan on thin endometrium in clomiphene induced ovulation cycle

Jin Fengyu ¹, Ruan Xiangyan ^1*, Qin Shuang ¹, Xu Xin ¹, Yang Yu ¹,Gu Muqing ¹, Li Yanqiu ¹, Du Juan¹, Cheng Jiaojiao ¹, Yin Xiaodan ²

1.Department of Gynecological Endocrinology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University / Beijing Maternal and Child Health Care Hospital, Beijing 100026, China；2. Department of Traditional Chinese Medicine, Beijing Obstetrics and Gynecology Hospital, Capital Medical University/Beijing Maternal and Child Health Care Hospital, Beijing 100026，China

Received:2023-05-09 Online:2023-08-21 Published:2023-07-26
Supported by:
This study was supported by Beijing Municipal Administration of Hospitals Incubating Program (PZ2019031), Beijing Municipal Administration of Hospitals' Ascent Plan (DFL20181401).

摘要/Abstract

摘要： 目的探讨定坤丹在氯米芬促排卵周期中对薄型子宫内膜的治疗效果，为临床提供依据。方法募集2018至2022年期间就诊于首都医科大学附属北京妇产医院内分泌科的患者，在氯米芬促排卵周期中呈现薄型子宫内膜共127例，在保证组间基本特征匹配原则上利用计算机软件产生的随机数随机分配到对照组和试验组。其中试验组64例给予定坤丹+戊酸雌二醇干预，对照组63例单纯给予戊酸雌二醇干预。治疗3个周期后对比两组患者之间人绒毛膜促性腺激素(human chorionic gonadotropin，HCG）日子宫内膜厚度、分型、黄体期孕激素浓度、3个周期排卵率、累计临床妊娠率的差异。结果 3个月后试验组和对照组患者HCG日平均子宫内膜厚度分别为（8.30±1.068 )mm 和(7.43±1.051 )mm，A型内膜占比分别为52.0%和32.7%。黄体期孕酮浓度分别为(11.00±1.508)ng/mL和(10.23±2.278)ng/mL，3个周期内排卵率分别为88.4% 和 79.7%，累计临床妊娠率分别为40.6%和22.2%，试验组均显著高于对照组（P<0.05）。结论定坤丹可以协同雌激素治疗氯米芬促排卵周期中子宫内膜过薄的问题，改善内膜型态、提高氯米芬排卵率、黄体功能以及临床妊娠率。

关键词: 氯米芬, 薄型子宫内膜, 内膜型态, 定坤丹, 排卵, 妊娠

Abstract: Objective To explore the effective of Dingkundan on thin endometrium in the clomiphene induced ovulation cycle, and provide basis for clinical practice. Methods A total of 127 patients who visited department of gynecological endocrinology, with thin endometrium in clomiphene induced ovulation cycle were recruited. Patients were randomly assigned to the control group and the experimental group based on the principle of ensuring basic feature comparable between groups. A total of 64 patients in experimental group were treated with Dingkun Pill+ estrodiol, while a total of 63 patients in control group were treated with estrodiol. The endometrial thickness and type on human chorionic gonadotropin（hCG） day, progesterone level, ovulation rate, and clinical pregnancy rate between the two groups were compared. Results The average endometrial thickness on hCG day in the experimental group was significantly higher than that in the control group［ (8.30±1.068) mm vs (7.43±1.051)mm, P<0.01］. The proportion of type A endometrium was significantly higher than that of the control group (52.0% vs 32.7%, P<0.05). The progesterone level in luteal phase was significantly higher than that in the control group ［(11.00±1.508)ng/mL vs (10.23±2.278)ng/mL, P<0.05］. The ovulation rate and the cumulative clinical pregnancy rate were significantly higher than that of the control group (88.4% vs 79.7%, P<0.05, and 40.6% vs 22.2%，P<0.05), respectively. Conclusions Dingkundan can cooperate with estrogen in the treatment of thin endometrium in the clomiphene reduced ovulation cycle, improve the endometrium type, and increase the ovulation rate of clomiphene, luteal function and clinical pregnancy rate.

Key words: clomiphene, thin endometrium, endometrium type, Dingkun Pill, ovualtion, pregnance

中图分类号:

R711.76

金凤羽, 阮祥燕, 秦爽, 许新, 杨瑜, 谷牧青, 李妍秋, 杜娟, 程姣姣, 尹晓丹. 定坤丹在氯米芬促排周期中对薄型子宫内膜的疗效观察[J]. 首都医科大学学报, 2023, 44(4): 550-554.

Jin Fengyu , Ruan Xiangyan , Qin Shuang , Xu Xin , Yang Yu , Gu Muqing , Li Yanqiu , Du Juan, Cheng Jiaojiao , Yin Xiaodan. Effect of Dingkundan on thin endometrium in clomiphene induced ovulation cycle[J]. Journal of Capital Medical University, 2023, 44(4): 550-554.

参考文献

［1］ Carson S A, Kallen A N. Diagnosis and management of infertility: a review［J］. JAMA, 2021, 326(1): 65-76.
［2］ Yu Q, Hu S F, Wang Y Y, et al. Letrozole versus laparoscopic ovarian drilling in clomiphene citrate-resistant women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials［J］. Reprod Biol Endocrinol, 2019, 17(1): 17.
［3］ Liu K E, Hartman M, Hartman A, et al. The impact of a thin endometrial lining on fresh and frozen-thaw IVF outcomes: an analysis of over 40 000 embryo transfers［J］. Hum Reprod, 2018, 33(10): 1883-1888.
［4］ Wadhwa L, Fauzdar A, Wadhwa S N. An intrauterine insemination audit at tertiary care hospital: a 4 years' retrospective analysis of 800 intrauterine insemination cycles［J］. J Hum Reprod Sci, 2018, 11(3): 279-285.
［5］ Kasius A, Smit J G, Torrance H L, et al. Endometrial thickness and pregnancy rates after IVF: a systematic review and meta-analysis［J］. Hum Reprod Update, 2014, 20(4): 530-541.
［6］张四友, 郑家凤. 氯米酚促排卵周期的特点和规律性再认识［J］. 生殖医学杂志, 2014, 23(6): 480-483.
［7］ Malhotra N, Bahadur A, Kalaivani M, et al. Changes in endometrial receptivity in women with Asherman's syndrome undergoing hysteroscopic adhesiolysis［J］. Arch Gynecol Obstet, 2012, 286(2): 525-530.
［8］尧淑梅. 定坤丹治疗排卵障碍性不孕症临床观察［J］. 光明中医, 2022, 37(13): 2363-2365.
［9］柯小红. 定坤丹治疗肾虚肝郁证月经过少的临床研究［J］. 实用中西医结合临床, 2022, 22(21): 64-66, 81.
［10］ Gonen Y, Casper R F. Prediction of implantation by the sonographic appearance of the endometrium during controlled ovarian stimulation for in vitro fertilization (IVF)［J］. J In Vitro Fert Embryo Transf, 1990, 7(3): 146-152.
［11］ Kunicki M Łukaszuk K, Woclawek-Potocka I, et al. Evaluation of granulocyte colony-stimulating factor effects on treatment-resistant thin endometrium in women undergoing in vitro fertilization［J］. Biomed Res Int, 2014, 2014: 913235.
［12］ Vaegter K K, Lakic T G, Olovsson M, et al. Which factors are most predictive for live birth after in vitro fertilization and intracytoplasmic sperm injection (IVF/ICSI) treatments? Analysis of 100 prospectively recorded variables in 8,400 IVF/ICSI single-embryo transfers［J］. Fertil Steril, 2017, 107(3): 641-648.e2.
［13］俞飞. 不同雌激素添加方案对氯米芬促排卵周期子宫内膜的影响［J］. 基层医学论坛, 2015, 19(29): 4038-4039.
［14］ Xu Z T, Ruan X Y, Xu X, et al. Efficacy and safety of Zi Gui Nv Zhen 􀅺 capsules used in TCM for fertility preservation in patients with diminished ovarian reserve［J］. Gynecol Endocrinol, 2022, 38(1): 73-77.
［15］郑娟, 谈勇. 定坤丹联合戊酸雌二醇对肾阳虚薄型子宫内膜大鼠Wnt/β-catenin信号通路的影响［J］. 四川大学学报: 医学版, 2021, 52(2): 235-240.
［16］刘艳红, 王霞, 李燕, 等. 补肾活血法联合芬吗通对薄型子宫内膜不孕症患者的临床疗效观察［J］. 生殖医学杂志, 2019, 28(5): 515-519.
［17］ Lin H, Liang Y L, Wang H B. Modern clinical application of Ding 1541［J］. Reprod Dev Med, 2018, 2(3): 178-182.
［18］李嘉慧, 欧妍. 定坤丹结合激素治疗肾虚肝郁证月经过少患者的临床疗效及对子宫内膜厚度的影响［J］. 世界中医药, 2018, 13(3): 669-671, 675.
［19］王海文, 阮祥燕, Wallwiener D, 等. 资癸女贞胶囊对子宫内膜薄性不育症妊娠结局影响的研究［J］. 首都医科大学学报, 2014, 35(4): 419-423.
［20］周冬梅, 滑玮, 黄艳红. 定坤丹对复苏周期子宫内膜及妊娠结局的影响［J］. 中国妇幼健康研究, 2018, 29(4): 511-513.
［21］钟丽珍, 艾丹, 许婷, 等. 定坤丹治疗肾阳虚证薄型子宫内膜不孕症的临床研究［J］. 医学理论与实践, 2022, 35(16): 2790-2792.
［22］ Liu S M, Zhou Y Z, Wang H B, et al. Factors associated with effectiveness of treatment and reproductive outcomes in patients with thin endometrium undergoing estrogen treatment［J］. Chin Med J (Engl), 2015, 128(23): 3173-3177.

定坤丹在氯米芬促排周期中对薄型子宫内膜的疗效观察

Effect of Dingkundan on thin endometrium in clomiphene induced ovulation cycle

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 0

编辑推荐

Metrics

本文评价